We are excited to announce that we will attend the 2026 SNMMI Annual Meeting, the premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging. 

The development of radiopharmaceutical solutions, whether for diagnostics or therapeutics, is full of challenges. Companies must navigate diverse regulatory landscapes, a complex payer environment with high prices and cost pressures, and varying levels of nuclear medicine maturity across geographies. 

Alira Health’s Nuclear Medicine Centre of Excellence can support biotech, pharma, and investors across the full product lifecycle—our capabilities span scientific, regulatory, clinical, manufacturing, commercialization, and market-access functions for both diagnostic and therapeutic radiopharmaceuticals. Reach out to our experts to learn how we can support your success.